Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Malignant Solid Tumors 1 HER2+ Metastatic Breast Cancer 1 Burkitt Lymphoma 1 Brain Neoplasms 1

Interventions

asciminib 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × HER2+ Metastatic Breast Cancer × asciminib × Clear all

NCT07136428 2026-05-06

ASCENdANT

Duke University

Phase 1/2 Not yet recruiting

HER2+ Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡